Developer docs
API playgroundTry for free, no card

Search company profiles

CleveMed

Full company profile

uuid000cive

Namestring
CleveMed
Legal namestring
Cleveland Medical Devices Inc.
Websiteurl
clevemed.com
Company typeenum
Private
Founded yearint
1990
Descriptiontext

CleveMed (legal name Cleveland Medical Devices Inc., now operating as Beacon Bio Dx, LLC dba CleveMed) is a Cleveland, Ohio-based medical device company founded in 1990 that develops, manufactures, and distributes wireless portable home sleep testing (HST) hardware, direct-to-patient fulfillment services, and cloud-based sleep study management software. Its product platform centers on the SleepView Monitor, an FDA-cleared AASM Type III seven-channel portable sleep apnea testing device that wirelessly transfers physiological data to the HIPAA-compliant SleepView Web Portal, complemented by SleepView Direct, a mail-order fulfillment service that ships devices directly to patient homes for telemedicine-enabled testing. The company also offers legacy portable monitors (Sapphire, SleepScout), an IDcheck biometric verification add-on, a published SleepView Web Portal API for partner integration, and registered SleepView, Crystal PSG, and eCrystal PSG trademarks.

CleveMed generates revenue through a mix of hardware unit sales and rentals (SleepView Monitor, Sapphire, SleepScout), recurring web portal subscription fees for cloud-based data management and scoring, professional services tied to direct-to-patient fulfillment and end-to-end HST workflow support, and channel revenue flowing through its exclusive U.S. distribution partner Roscoe Medical. Pricing is quote-based for providers, with home sleep testing delivered at less than a quarter of the cost of in-lab polysomnography. The company distributes through direct enterprise sales to sleep labs and large health systems, the Roscoe Medical dealer network, the Welltrinsic sleep network, a Premier Inc. GPO agreement, and a self-serve web portal. Target buyers span sleep specialists, primary care practices and nurse practitioners, cardiology groups, corporate wellness programs, retail clinics, and ENTs/dental sleep medicine providers. The product portfolio is backed by over 20 issued and 27 pending US and foreign patents, ISO 13485 and ISO 27001 certifications, ACHC accreditation, and CE marking.

On April 21, 2025, CleveMed was acquired by Beacon Biosignals, a neurotechnology company specializing in at-home EEG and AI-driven brain monitoring, and was fully integrated under the Beacon brand by mid-2026. The combined platform extends CleveMed's HST infrastructure with AI-driven EEG scoring algorithms, expanding data capture to include airflow, respiratory effort, and oxygen saturation alongside direct brain activity measurement, and supports pharma data-licensing programs such as the disclosed multi-year partnership with Takeda. Under Beacon ownership, CleveMed's leadership (President and CEO Hani Kayyali, founder and Chairman Robert Schmidt) continues to operate the HST business while serving as the HST infrastructure layer within a broader neurodiagnostic and neurobiomarker platform.

Short descriptiontext

CleveMed, founded in 1990 in Cleveland, Ohio, designs FDA-cleared portable home sleep testing devices, direct-to-patient fulfillment services, and cloud-based sleep study management software, serving sleep labs, primary care, cardiology, and corporate wellness customers. Since April 2025 it has operated as a subsidiary of Beacon Biosignals, integrating HST infrastructure with AI-driven EEG-based brain monitoring.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCleveland, United States
HQ citystring
Cleveland
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
home sleep testing, portable sleep monitors, sleep apnea diagnostics, polysomnography devices, medical device manufacturing
Industry2 codes
PRIMARYHLAHAGAB
Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLALAGAF
Pulmonology & Sleep Medicine Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code2 codes
  • Home Health Care Services6216
  • Home Health Equipment Rental532283
SIC code1 code
  • Services-Health Services8000
Product category
Home Sleep Testing Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Home Sleep Testing Devices
TypeHardware Sales
Description

Sale/rental of portable sleep monitoring devices (SleepView Monitor, Sapphire, SleepScout) to healthcare providers including sleep labs, primary care practices, and cardiology groups.

clevemed.com
2Sleep Testing Services
TypeProfessional Services
Description

Fulfillment services including device mailing to patients' homes, data management, scoring, and interpretation services through the SleepView Web Portal. Provides end-to-end home sleep testing workflow solutions.

clevemed.com
3Software/SaaS Platform
TypeSubscription Recurring
Description

Web-based software subscriptions for data management, secured online access, and cloud-based portal services for sleep study management.

clevemed.com
4Distribution/Channel Revenue
TypeHardware Sales
Description

Revenue through exclusive distribution partnership with Roscoe Medical for SleepView Monitor sales in the United States.

clevemed.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Operations, Marketing or Sales, Personnel, Supply Chain, Infrastructure
Pricing details3 tiers
1SleepView Monitor device sales
ModelUnit PricingBilling cadenceOne time/ perpetual license
Notes

FDA-cleared portable home sleep monitor - specific pricing not publicly disclosed. Quote-based for healthcare providers.

clevemed.com
2SleepView Direct fulfillment service
ModelOtherBilling cadenceMonthly
Notes

Direct-to-patient home testing service including device delivery, data collection, and management. Pricing varies by provider and volume.

clevemed.com
3Web Portal subscription
ModelSubscriptionBilling cadenceMonthly
Notes

Cloud-based data management and scoring platform subscription for sleep study management.

clevemed.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1SleepView
Description

Home sleep testing device and associated web portal for portable sleep apnea diagnosis

clevemed.com
+3 more records
Core offering1 text field

CleveMed designs, manufactures, and distributes FDA-cleared portable home sleep apnea testing (HST) devices and related fulfillment and software services. Its flagship SleepView Monitor is a Type III portable HST device that meets American Academy of Sleep Medicine channel guidelines, complemented by SleepView Direct (a mail-order, direct-to-patient fulfillment service) and the SleepView Web Portal (a HIPAA-compliant cloud platform for study scheduling, scoring, interpretation, and reporting). The vertically integrated offering enables physicians and health systems to deliver cost-effective sleep diagnostics outside of traditional sleep labs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Sleep study capacity expansion without capital expenditure for healthcare providers
+2 more records
Product overview1 text field

CleveMed provides an integrated home sleep testing ecosystem centered on the SleepView product family. The core SleepView Monitor is a Type III portable home sleep apnea testing device meeting AASM channel guidelines, while SleepView Direct provides mail-order fulfillment delivering devices directly to patients. The SleepView Web Portal enables web-based data management, scheduling, and clinic workflow integration. The platform incorporates automated scoring algorithms for respiratory event detection and sleep time estimation, with manual over-read by registered polysomnographic technologists. Legacy products include Sapphire and SleepScout portable sleep monitors. Following acquisition by Beacon Biosignals in April 2025, CleveMed operates as part of Beacon Biosignals with full brand integration completed in 2026, expanding to include respiratory and oxygen saturation data alongside EEG-based brain monitoring.

Product and service1 record
1SleepView Monitor
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-23
Description

Multi-year partnership with Takeda (up to $109 million in data license fees and development milestones) using CleveMed/Beacon's at-home EEG headband and cloud AI platform for narcolepsy diagnostics and neurobiomarker development. Takeda is strategic investor in Beacon Biosignals.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-04-21
Description

Beacon Biosignals acquired CleveMed in strategic transaction combining Beacon's AI-driven EEG and brain monitoring with CleveMed's home sleep testing technology. Integration creates most advanced EEG-based home sleep testing platform.

3Sleep Care Online
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-07-02
Description

Sleep Care Online combines telemedicine and home sleep apnea testing with board-certified physicians and sleep coaches. Integration with CleveMed's SleepView technology.

clevemed.com
4Welltrinsic
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2015-10-29
Description

Partnership with Welltrinsic sleep network to offer home sleep apnea testing using CleveMed's technologies nationwide. Welltrinsic represents a large group of sleep centers and physicians.

clevemed.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2014-09-03
Description

Partnership expansion of sleep apnea pilot program at on-site health clinics across Florida to 7 sites using CleveMed technologies.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2014-06-10
Description

Group purchasing agreement for Sleep Diagnostic Services with Premier, Inc. Effective June 1, 2014, allowing Premier members access to special pricing and terms.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2014-04-01
Description

AMS selected CleveMed's SleepView as exclusive device for Home Sleep Testing. AMS has nearly 200 sales territories across the country for market education.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-11-21
Description

5-year pioneering collaboration with CCP, one of the largest cardiology practices in the U.S., and local sleep centers for specialty practice accreditation. CleveMed technology enabled integrated cardiac-sleep care programs.

9Roscoe Medical
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2013-03-12
Description

Strategic partnership making Roscoe Medical the exclusive U.S. distributor of SleepView Monitor. Roscoe Medical, manufacturer and distributor of home medical equipment, serves customers throughout the U.S., Canada, and Puerto Rico through their dealer network.

clevemed.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers4 records
TypeDirect peer
TypeBroad incumbent
Description

Global leader in sleep apnea therapy (CPAP/APAP) that also sells home sleep testing devices such as ApneaLink Air and the recently acquired Verily/Alix partner ecosystem. Directly comparable to CleveMed as a competing HST device plus broader sleep franchise, but with vastly greater scale and a dominant therapy-installed base.

TypeDirect peer
Description

WatchPAT is a wrist-based, FDA-cleared Type III home sleep apnea test using peripheral arterial tonometry, competing head-to-head with SleepView in cardiology and primary care HST workflows; now part of ZOLL Medical, giving it stronger distribution than CleveMed.

TypeBroad incumbent
Description

Incumbent in sleep diagnostics and therapy, offering Alice NightOne home sleep testing devices plus the full Alice PSG in-lab line and DreamStation CPAP/APAP. Direct overlap with CleveMed's SleepView Type III HST and broader sleep lab channel.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CleveMed

Home Sleep Testing Devicesclevemed.com

CleveMed, founded in 1990 in Cleveland, Ohio, designs FDA-cleared portable home sleep testing devices, direct-to-patient fulfillment services, and cloud-based sleep study management software, serving sleep labs, primary care, cardiology, and corporate wellness customers. Since April 2025 it has operated as a subsidiary of Beacon Biosignals, integrating HST infrastructure with AI-driven EEG-based brain monitoring.

What CleveMed does

CleveMed (legal name Cleveland Medical Devices Inc., now operating as Beacon Bio Dx, LLC dba CleveMed) is a Cleveland, Ohio-based medical device company founded in 1990 that develops, manufactures, and distributes wireless portable home sleep testing (HST) hardware, direct-to-patient fulfillment services, and cloud-based sleep study management software. Its product platform centers on the SleepView Monitor, an FDA-cleared AASM Type III seven-channel portable sleep apnea testing device that wirelessly transfers physiological data to the HIPAA-compliant SleepView Web Portal, complemented by SleepView Direct, a mail-order fulfillment service that ships devices directly to patient homes for telemedicine-enabled testing. The company also offers legacy portable monitors (Sapphire, SleepScout), an IDcheck biometric verification add-on, a published SleepView Web Portal API for partner integration, and registered SleepView, Crystal PSG, and eCrystal PSG trademarks.

CleveMed generates revenue through a mix of hardware unit sales and rentals (SleepView Monitor, Sapphire, SleepScout), recurring web portal subscription fees for cloud-based data management and scoring, professional services tied to direct-to-patient fulfillment and end-to-end HST workflow support, and channel revenue flowing through its exclusive U.S. distribution partner Roscoe Medical. Pricing is quote-based for providers, with home sleep testing delivered at less than a quarter of the cost of in-lab polysomnography. The company distributes through direct enterprise sales to sleep labs and large health systems, the Roscoe Medical dealer network, the Welltrinsic sleep network, a Premier Inc. GPO agreement, and a self-serve web portal. Target buyers span sleep specialists, primary care practices and nurse practitioners, cardiology groups, corporate wellness programs, retail clinics, and ENTs/dental sleep medicine providers. The product portfolio is backed by over 20 issued and 27 pending US and foreign patents, ISO 13485 and ISO 27001 certifications, ACHC accreditation, and CE marking.

On April 21, 2025, CleveMed was acquired by Beacon Biosignals, a neurotechnology company specializing in at-home EEG and AI-driven brain monitoring, and was fully integrated under the Beacon brand by mid-2026. The combined platform extends CleveMed's HST infrastructure with AI-driven EEG scoring algorithms, expanding data capture to include airflow, respiratory effort, and oxygen saturation alongside direct brain activity measurement, and supports pharma data-licensing programs such as the disclosed multi-year partnership with Takeda. Under Beacon ownership, CleveMed's leadership (President and CEO Hani Kayyali, founder and Chairman Robert Schmidt) continues to operate the HST business while serving as the HST infrastructure layer within a broader neurodiagnostic and neurobiomarker platform.

CleveMed firmographics

Firmographics
Name
CleveMed
Legal name
Cleveland Medical Devices Inc.
Website
https://clevemed.com
Company type
Private
Founded year
1990
Operating status
Acquired
Headcount range
11–50 employees
Short description
CleveMed, founded in 1990 in Cleveland, Ohio, designs FDA-cleared portable home sleep testing devices, direct-to-patient fulfillment services, and cloud-based sleep study management software, serving sleep labs, primary care, cardiology, and corporate wellness customers. Since April 2025 it has operated as a subsidiary of Beacon Biosignals, integrating HST infrastructure with AI-driven EEG-based brain monitoring.
Ownership category
akta.pro rank

CleveMed industry classification

Industry
Product category
Home Sleep Testing Devices
NAICS
Home Health Care Services (6216), Home Health Equipment Rental (532283)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAHAGAB
Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLALAGAF
Pulmonology & Sleep Medicine Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • Home sleep testing
  • Portable sleep monitors
  • Sleep apnea diagnostics
  • Polysomnography devices
  • Medical device manufacturing

Where CleveMed is headquartered

Location

Headquarters

HQ city
Cleveland
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CleveMed business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Marketing or Sales, Personnel, Supply Chain, Infrastructure

Revenue model

  1. Home Sleep Testing Devices: Sale/rental of portable sleep monitoring devices (SleepView Monitor, Sapphire, SleepScout) to healthcare providers including sleep labs, primary care practices, and cardiology groups.
  2. Sleep Testing Services: Fulfillment services including device mailing to patients' homes, data management, scoring, and interpretation services through the SleepView Web Portal. Provides end-to-end home sleep testing workflow solutions.
  3. Software/SaaS Platform: Web-based software subscriptions for data management, secured online access, and cloud-based portal services for sleep study management.
  4. Distribution/Channel Revenue: Revenue through exclusive distribution partnership with Roscoe Medical for SleepView Monitor sales in the United States.

Pricing tiers

ModelBillingPrice
Unit PricingOne time/ perpetual licenseSleepView Monitor device sales
OtherMonthlySleepView Direct fulfillment service
SubscriptionMonthlyWeb Portal subscription

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

CleveMed product offering

Product offering

Core offering

CleveMed designs, manufactures, and distributes FDA-cleared portable home sleep apnea testing (HST) devices and related fulfillment and software services. Its flagship SleepView Monitor is a Type III portable HST device that meets American Academy of Sleep Medicine channel guidelines, complemented by SleepView Direct (a mail-order, direct-to-patient fulfillment service) and the SleepView Web Portal (a HIPAA-compliant cloud platform for study scheduling, scoring, interpretation, and reporting). The vertically integrated offering enables physicians and health systems to deliver cost-effective sleep diagnostics outside of traditional sleep labs.

Product overview

CleveMed provides an integrated home sleep testing ecosystem centered on the SleepView product family. The core SleepView Monitor is a Type III portable home sleep apnea testing device meeting AASM channel guidelines, while SleepView Direct provides mail-order fulfillment delivering devices directly to patients. The SleepView Web Portal enables web-based data management, scheduling, and clinic workflow integration. The platform incorporates automated scoring algorithms for respiratory event detection and sleep time estimation, with manual over-read by registered polysomnographic technologists. Legacy products include Sapphire and SleepScout portable sleep monitors. Following acquisition by Beacon Biosignals in April 2025, CleveMed operates as part of Beacon Biosignals with full brand integration completed in 2026, expanding to include respiratory and oxygen saturation data alongside EEG-based brain monitoring.

Differentiator

Problem solved

Functional benefit

Brands

  • SleepView: Home sleep testing device and associated web portal for portable sleep apnea diagnosis
  • SleepView Monitor
  • SleepView Direct
  • SleepView Web Portal

Products and services

  • SleepView Monitor

Quantifiable outcome

  • Sleep study capacity expansion without capital expenditure for healthcare providers
  • +2 more outcomes

Companies that use CleveMed

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles4 records

CleveMed technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

CleveMed partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core, flagship and minor.

  • TakedacoreStrategic or Co-development Partner · 23 September 2025Multi-year partnership with Takeda (up to $109 million in data license fees and development milestones) using CleveMed/Beacon's at-home EEG headband and cloud AI platform for narcolepsy diagnostics and neurobiomarker development. Takeda is strategic investor in Beacon Biosignals.
  • Beacon BiosignalsflagshipStrategic or Co-development Partner · 21 April 2025Beacon Biosignals acquired CleveMed in strategic transaction combining Beacon's AI-driven EEG and brain monitoring with CleveMed's home sleep testing technology. Integration creates most advanced EEG-based home sleep testing platform.
  • Sleep Care OnlineminorStrategic or Co-development Partner · 2 July 2019Sleep Care Online combines telemedicine and home sleep apnea testing with board-certified physicians and sleep coaches. Integration with CleveMed's SleepView technology.
  • WelltrinsiccoreChannel Partner/ Reseller/ Distributor · 29 October 2015Partnership with Welltrinsic sleep network to offer home sleep apnea testing using CleveMed's technologies nationwide. Welltrinsic represents a large group of sleep centers and physicians.
  • Crowne/CareHereminorStrategic or Co-development Partner · 3 September 2014Partnership expansion of sleep apnea pilot program at on-site health clinics across Florida to 7 sites using CleveMed technologies.
  • Premier, Inc.coreChannel Partner/ Reseller/ Distributor · 10 June 2014Group purchasing agreement for Sleep Diagnostic Services with Premier, Inc. Effective June 1, 2014, allowing Premier members access to special pricing and terms.
  • Ancillary Medical Solutions (AMS)minorChannel Partner/ Reseller/ Distributor · 1 April 2014AMS selected CleveMed's SleepView as exclusive device for Home Sleep Testing. AMS has nearly 200 sales territories across the country for market education.
  • Cardiology Consultants of Philadelphia (CCP)coreStrategic or Co-development Partner · 21 November 20135-year pioneering collaboration with CCP, one of the largest cardiology practices in the U.S., and local sleep centers for specialty practice accreditation. CleveMed technology enabled integrated cardiac-sleep care programs.
  • Roscoe MedicalcoreChannel Partner/ Reseller/ Distributor · 12 March 2013Strategic partnership making Roscoe Medical the exclusive U.S. distributor of SleepView Monitor. Roscoe Medical, manufacturer and distributor of home medical equipment, serves customers throughout the U.S., Canada, and Puerto Rico through their dealer network.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

CleveMed competitors and assessment

Company assessment

Direct peers

  • Nox Medical:
  • Itamar Medical (ZOLL Itamar): WatchPAT is a wrist-based, FDA-cleared Type III home sleep apnea test using peripheral arterial tonometry, competing head-to-head with SleepView in cardiology and primary care HST workflows; now part of ZOLL Medical, giving it stronger distribution than CleveMed.

Broad incumbents

  • ResMed: Global leader in sleep apnea therapy (CPAP/APAP) that also sells home sleep testing devices such as ApneaLink Air and the recently acquired Verily/Alix partner ecosystem. Directly comparable to CleveMed as a competing HST device plus broader sleep franchise, but with vastly greater scale and a dominant therapy-installed base.
  • Philips Respironics: Incumbent in sleep diagnostics and therapy, offering Alice NightOne home sleep testing devices plus the full Alice PSG in-lab line and DreamStation CPAP/APAP. Direct overlap with CleveMed's SleepView Type III HST and broader sleep lab channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

CleveMed social profiles

Digital presence

CleveMed compliance and trust

Trust signal

Compliance4 records

CleveMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CleveMed leadership team

Management profile

Number of profiles

Profiles2 records

CleveMed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CleveMed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CleveMed

What does CleveMed do?

CleveMed designs, manufactures, and distributes FDA-cleared portable home sleep apnea testing (HST) devices and related fulfillment and software services. Its flagship SleepView Monitor is a Type III portable HST device that meets American Academy of Sleep Medicine channel guidelines, complemented by SleepView Direct (a mail-order, direct-to-patient fulfillment service) and the SleepView Web Portal (a HIPAA-compliant cloud platform for study scheduling, scoring, interpretation, and reporting). The vertically integrated offering enables physicians and health systems to deliver cost-effective sleep diagnostics outside of traditional sleep labs.

Is CleveMed a public or private company?

CleveMed is a private company. It is classified as corporate owned and is currently acquired.

When was CleveMed founded?

CleveMed was founded in 1990. It employs 11 to 50 people.

Where is CleveMed based?

CleveMed is headquartered in Cleveland, United States, in the North America region.

How does CleveMed make money?

Four revenue lines are on record. Home Sleep Testing Devices are the primary driver. The others are sleep Testing Services, software/SaaS Platform and distribution/Channel Revenue.

Who are CleveMed's main competitors?

Direct peers on record are Nox Medical and Itamar Medical (ZOLL Itamar). Broad incumbents are ResMed and Philips Respironics.

Does CleveMed have an API?

Yes. CleveMed released the SleepViewSM Web Portal API, enabling external developers and partners to integrate with CleveMed's home sleep testing platform. The API facilitates data exchange for scheduling studies, uploading monitor data, and accessing raw data for scoring and interpretation. Developer documentation is at www.clevemedsleepview.com.

What industry is CleveMed in?

CleveMed's product category is Home Sleep Testing Devices. Its primary akta.pro industry code is HLAHAGAB, Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy), with a secondary code of HLALAGAF, Pulmonology & Sleep Medicine Telemedicine Platforms. Its NAICS code is 6216 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mugglehead MagazineFive technologies moving from science fiction to reality: A Mugglehead roundupThis Mugglehead roundup profiles five emerging technologies moving from concept toward clinical or commercial deployment, spanning healthcare diagnostics, remote surgery, and nuclear energy. The article covers home sleep diagnostics through Beacon Biosignals' acquisition of CleveMed, microvascular heart disease assessment via CoroFlow, breath-based lung cancer screening from Owlstone Medical and Breath Diagnostics, remote robotic surgery involving Intuitive Surgical, Medtronic, Johnson & Johnson, and MicroPort MedBot's Toumai system, and Deep Fission's below-ground small modular reactor design. Each technology targets longstanding limitations in current practice—whether expanding access, improving diagnostic accuracy, or reducing infrastructure costs—with varying stages of commercialization ranging from early research to FDA-authorized procedures already performed across continents.GlobeNewswireBeacon Biosignals Unifies Brands, Bringing CleveMed and SleepView® Under the Beacon NameBeacon Biosignals announced the full integration of CleveMed into the Beacon brand, consolidating technology, services, and clinical expertise under one name. The SleepView device and SleepView Direct home testing service will now operate as part of Beacon Biosignals, combining CleveMed's home sleep testing infrastructure with Beacon's AI-driven brain monitoring technology. The company stated this integration creates what it claims is the most advanced EEG-based home sleep testing platform in the country.ClevemedCleveMed Parent Company Beacon Biosignals Raises $86M to Advance Sleep and CNS DiagnosticsBeacon Biosignals, parent company of CleveMed, has completed an $86 million funding round to accelerate the advancement of its artificial intelligence technologies for brain health diagnostics. The investment will support the development of AI-powered solutions for diagnosing, monitoring, and treating neurological, sleep, and psychiatric conditions. As part of the Beacon Biosignals family, CleveMed will leverage the funding to expand its home sleep testing operations, which currently serve more than 10,000 sleep studies monthly across U.S. health systems.ClevemedBeacon Biosignals Acquires CleveMedBeacon Biosignals, a neurotechnology company specializing in at-home EEG and AI-powered sleep diagnostics, has acquired CleveMed, a leader in Home Sleep Testing technology and services. The strategic transaction combines Beacon's AI-driven sleep scoring algorithms with CleveMed's SleepView devices and web-based monitoring technologies to expand capabilities in home-based sleep disorder diagnosis. The merged entity aims to improve patient access to quality care while reducing healthcare costs for payers.BeaconBeacon Biosignals Completes Strategic Transaction to Acquire CleveMedBeacon Biosignals has completed the acquisition of CleveMed, a leader in Home Sleep Testing technology and services, in a strategic transaction announced on April 21, 2025. The deal will integrate Beacon Biosignals' AI-driven algorithms with CleveMed's existing sleep testing devices and web-based technologies, including SleepView products. Both companies stated the partnership aims to expand access to quality sleep care and address future sleep testing needs while reducing healthcare costs for payers.Sleep ReviewWhen Lease Is MoreSleep physicians and sleep centers are increasingly financing diagnostic equipment like home sleep testing devices through leasing or rental programs rather than purchasing outright, with about 62% of medical equipment acquisitions currently financed. Companies including CleveMed, CareFusion, Advanced Brain Monitoring, and SleepMed offer rental and lease programs specifically designed for sleep diagnostic equipment, allowing practices to start testing with minimal upfront costs. The article outlines advantages of equipment financing such as improved cash flow, easier budget approvals, maintenance coverage, tax benefits, and access to technology upgrades, while also noting downsides including higher long-term costs.